Exodus Point Capital Management, LP Zai Lab LTD Transaction History

Exodus Point Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$22.72 - $31.49 $1.99 Million - $2.76 Million	87,640 Added 153.22%	144,838 $3.52 Million
Q2 2023 Aug 10, 2023	BUY	$25.3 - $39.67 $1.45 Million - $2.27 Million	57,198 New	57,198 $1.59 Million
Q4 2021 Feb 11, 2022	SELL	$54.9 - $105.21 $112,709 - $215,996	-2,053 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $4,725 - $8,026	45 Added 2.24%	2,053 $216,000
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $251,220 - $361,440	2,008 New	2,008 $355,000
Q4 2020 Feb 16, 2021	SELL	$81.94 - $135.34 $946,734 - $1.56 Million	-11,554 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$73.3 - $89.48 $846,908 - $1.03 Million	11,554 New	11,554 $961,000
Q1 2020 May 15, 2020	SELL	$39.1 - $62.9 $9.32 Million - $15 Million	-238,463 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $2.73 Million - $3.94 Million	91,491 Added 62.25%	238,463 $9.92 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $4.19 Million - $5.18 Million	137,663 Added 1478.82%	146,972 $4.76 Million
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $239,520 - $333,169	9,309 New	9,309 $325,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.